Table 4.
Prospective studies on travel-associated colonization with ESBL-producing Enterobacteriaceae – rates and risk factors
| Travellers (n) overall | Colonization rate (%) overall | Travellers (n) India/Indian subcontinent | Colonization rate (%) India/Indian subcontinent | Risk factors* | |
|---|---|---|---|---|---|
| Current study | 170 | 69.4 | 68 | 86.8 | Travel Destination |
| Length of Stay | |||||
| Visiting Friends and Relatives | |||||
| Consumption of Ice Cream & Pastry | |||||
| Tängden et al. [8] | 100 | 24.0 | 8 | 88.0 | Travelling to India |
| Gastroenteritis during Trip | |||||
| Kennedy et al. [9]a | 102 | 21.6 | 14 | 57.1 | Gastroenteritis during Trip |
| Antibiotics while Travelling | |||||
| Weisenberg et al. [10] | 28 | 25.0 | 7b | 28.6 | not done |
| Paltansing et al. [11] | 370 | 30.5 | 25c | 73.0c | Travelling to South and East Asia |
| Östholm-Balkhed et al. [12] | 226 | 30.0 | 14 | 71.4 | Travelling to Indian subcontinent, Asia, Africa north of equator |
| Age | |||||
| Gastroenteritis during Trip |
*Risk factors for becoming colonized for all the countries included in the respective study.
arisk factor for colonization with E. coli resistant to gentamicin, ciprofloxacin and/or third-generation cephalosporins.
bSouth Asia (not specified).
cSouth Asia: Bangladesh, India, Maldives, Nepal and Sri Lanka.